(Q49173192)

English

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults.

scientific article published in November 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

Hepatitis B vaccine

1 reference

based on heuristic

inferred from title

author name string

Leroux-Roels G

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

Desombere I

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

De Tollenaere G

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

Petit MA

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

Desmons P

5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

Hauser P

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

Delem A

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

De Grave D

8

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

Safary A

9

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

language of work or name

0 references

publication date

1 November 1997

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

15

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

16

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

1724-1731

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of cellular immunity to hepatitis-B-virus antigens from the early incubation phase of acute hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

An Antibody Which Precipitates Dane Particles in Acute Hepatitis Type B: Relation to Receptor Sites Which Bind Polymerized Human Serum Albumin on Virus Particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus pre-S gene-encoded antigenic specificity and anti-pre-S antibody: relationship between anti-pre-S response and recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody to the receptor for polymerized human serum albumin in acute and persistent infection with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody response to pre-S2 and hepatitis B virus induced liver damage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic restriction of immune responsiveness to synthetic peptides corresponding to sequences in the pre-S region of the hepatitis B virus (HBV) envelope gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Large hepatitis B surface antigen polypeptides of Dane particles with the receptor for polymerized human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Demonstration of albumin receptors onisolated human hepatocytes by light and scanning electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine-induced escape mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900117-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(97)00117-5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/9364674

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49173192&oldid=1566762079"